{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:12:59Z","timestamp":1791943979426,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.mayocp.2023.08.014","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T03:02:48Z","timestamp":1706842968000},"page":"593-606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Clinicopathologic Characteristics, Etiologies, and Outcome of Secondary Oxalate Nephropathy"],"prefix":"10.1016","volume":"99","author":[{"given":"Samih H.","family":"Nasr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Valeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar M.","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl A.","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Lieske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mayocp.2023.08.014_bib1","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.ekir.2018.07.020","article-title":"Secondary oxalate nephropathy: a systematic review","volume":"3","author":"Lumlertgul","year":"2018","journal-title":"Kidney Int Rep"},{"issue":"2","key":"10.1016\/j.mayocp.2023.08.014_bib2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/ckj\/sfab145","article-title":"Oxalate nephropathy: a review","volume":"15","author":"Rosenstock","year":"2022","journal-title":"Clin Kidney J"},{"issue":"12","key":"10.1016\/j.mayocp.2023.08.014_bib3","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.ekir.2022.09.002","article-title":"Increased rates of supplement-associated oxalate nephropathy during COVID-19 pandemic","volume":"7","author":"Fong","year":"2022","journal-title":"Kidney Int Rep"},{"issue":"5","key":"10.1016\/j.mayocp.2023.08.014_bib4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5414\/CN109980","article-title":"Kidney oxalate crystal deposition in adult patients: a relatively common finding","volume":"93","author":"Yang","year":"2020","journal-title":"Clin Nephrol"},{"issue":"9","key":"10.1016\/j.mayocp.2023.08.014_bib5","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.ekir.2020.06.021","article-title":"Etiologies, clinical features, and outcome of oxalate nephropathy","volume":"5","author":"Buysschaert","year":"2020","journal-title":"Kidney Int Rep"},{"issue":"12","key":"10.1016\/j.mayocp.2023.08.014_bib6","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1159\/000520286","article-title":"Clinical outcomes and histological patterns in oxalate nephropathy due to enteric and nonenteric risk factors","volume":"52","author":"Reddy","year":"2021","journal-title":"Am J Nephrol"},{"issue":"6","key":"10.1016\/j.mayocp.2023.08.014_bib7","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.2215\/CJN.02940608","article-title":"Oxalate nephropathy complicating Roux-en-Y gastric bypass: an underrecognized cause of irreversible renal failure","volume":"3","author":"Nasr","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.mayocp.2023.08.014_bib8","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2215\/CJN.00010111","article-title":"Oxalate nephropathy associated with chronic pancreatitis","volume":"6","author":"Cartery","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.mayocp.2023.08.014_bib9","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1053\/j.ajkd.2012.02.342","article-title":"Subclinical celiac disease and crystal-induced kidney disease following kidney transplant","volume":"60","author":"Capolongo","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2023.08.014_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/j.ajkd.2006.10.004","article-title":"Acute oxalate nephropathy associated with orlistat, a gastrointestinal lipase inhibitor","volume":"49","author":"Singh","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.mayocp.2023.08.014_bib11","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1681\/ASN.2010010010","article-title":"Pathologic classification of diabetic nephropathy","volume":"21","author":"Tervaert","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.mayocp.2023.08.014_bib12","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1373\/clinchem.2005.054353","article-title":"Sensitive spectrophotometric assay for plasma oxalate","volume":"51","author":"Ladwig","year":"2005","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.mayocp.2023.08.014_bib13","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"10.1016\/j.mayocp.2023.08.014_bib14","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int"},{"issue":"19","key":"10.1016\/j.mayocp.2023.08.014_bib15","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"Chronic Kidney Disease Epidemiology Collaboration. New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.mayocp.2023.08.014_bib16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"18","key":"10.1016\/j.mayocp.2023.08.014_bib17","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.clinbiochem.2017.07.017","article-title":"Plasma oxalate in relation to eGFR in patients with primary hyperoxaluria, enteric hyperoxaluria and urinary stone disease","volume":"50","author":"Perinpam","year":"2017","journal-title":"Clin Biochem"},{"issue":"7","key":"10.1016\/j.mayocp.2023.08.014_bib18","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/ndt\/gfad049","article-title":"Plasma oxalate and glycolate concentrations in dialysis patients with and without primary hyperoxaluria type 1","volume":"38","author":"Metry","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.mayocp.2023.08.014_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1053\/j.ajkd.2022.11.016","article-title":"Acute kidney injury and hair-straightening products: a case series","volume":"82","author":"Bnaya","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mayocp.2023.08.014_bib20","article-title":"Acute oxalate nephropathy: a potential cause of acute kidney injury in diabetes mellitus\u2014a case series from a single center","volume":"9","author":"Bao","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10.1016\/j.mayocp.2023.08.014_bib21","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jamainternmed.2018.7980","article-title":"Chronic Renal Insufficiency Cohort study Investigators. Association of urinary oxalate excretion with the risk of chronic kidney disease progression","volume":"179","author":"Waikar","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.mayocp.2023.08.014_bib22","article-title":"Glyoxylate, a new marker metabolite of type 2 diabetes","volume":"2014","author":"Nikiforova","year":"2014","journal-title":"J\u00a0Diabetes Res"},{"key":"10.1016\/j.mayocp.2023.08.014_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/819202","article-title":"Glyoxal formation and its role in endogenous oxalate synthesis","volume":"2012","author":"Lange","year":"2012","journal-title":"Adv Urol"},{"issue":"6","key":"10.1016\/j.mayocp.2023.08.014_bib24","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1681\/ASN.2017111213","article-title":"Oral antibiotic exposure and kidney stone disease","volume":"29","author":"Tasian","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"suppl 14","key":"10.1016\/j.mayocp.2023.08.014_bib25","first-page":"S457","article-title":"Crystal-cell interaction and apoptosis in oxalate-associated injury of renal epithelial cells","volume":"10","author":"Khan","year":"1999","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.mayocp.2023.08.014_bib26","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/j.1523-1755.2005.00566.x","article-title":"Crystals cause acute necrotic cell death in renal proximal tubule cells, but not in collecting tubule cells","volume":"68","author":"Schepers","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.mayocp.2023.08.014_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10274","article-title":"Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis","volume":"7","author":"Mulay","year":"2016","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.mayocp.2023.08.014_bib28","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1681\/ASN.2018121218","article-title":"Mitochondria permeability transition versus necroptosis in oxalate-induced AKI","volume":"30","author":"Mulay","year":"2019","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.mayocp.2023.08.014_bib29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1172\/JCI63679","article-title":"Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1\u03b2 secretion","volume":"123","author":"Mulay","year":"2013","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.mayocp.2023.08.014_bib30","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/ki.2013.207","article-title":"NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy","volume":"84","author":"Knauf","year":"2013","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.mayocp.2023.08.014_bib31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrneph.2017.10","article-title":"Crystal nephropathies: mechanisms of crystal-induced kidney injury","volume":"13","author":"Mulay","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.mayocp.2023.08.014_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110236","article-title":"Alpha-tubulin relocalization is involved in calcium oxalate-induced tight junction disruption in renal epithelial cells","volume":"368","author":"Hadpech","year":"2022","journal-title":"Chem Biol Interact"},{"issue":"1","key":"10.1016\/j.mayocp.2023.08.014_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/labinvest.2010.167","article-title":"Effects of calcium oxalate monohydrate crystals on expression and function of tight junction of renal tubular epithelial cells","volume":"91","author":"Peerapen","year":"2011","journal-title":"Lab Invest"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561962300407X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561962300407X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T10:18:35Z","timestamp":1711966715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002561962300407X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S002561962300407X"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2023.08.014","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathologic Characteristics, Etiologies, and Outcome of Secondary Oxalate Nephropathy","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2023.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}